MLN4924 (Pevonedistat), a neddylation inhibitor that specifically blocks NAE1, was able to induce cell migration in p53-null cancer cells by upregulating the PI3K/Akt/mTOR/Slug signaling axis. This evidence concerns the gene TP53 and cancer.